OPKO Health
OPK
#5814
Rank
A$1.84 B
Marketcap
A$2.49
Share price
0.00%
Change (1 day)
22.27%
Change (1 year)

Earnings for OPKO Health (OPK)

Earnings in 2026 (TTM): -A$0.24 Billion

According to OPKO Health 's latest financial reports the company's current earnings are A$0.50 Billion. In 2025 the company made an earning of -A$0.48 Billion a decrease over its 2024 earnings that were of -A$15.09 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for OPKO Health from 1996 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -A$0.24 Billion-50.76%
2025 -A$0.48 Billion3024.22%
2024 -A$15.09 Million-94.38%
2023 -A$0.27 Billion-52.92%
2022 -A$0.57 Billion2691.58%
2021 -A$20.42 Million-128.81%
2020 A$70.84 M-115.96%
2019 -A$0.45 Billion72.03%
2018 -A$0.26 Billion-33.83%
2017 -A$0.39 Billion264.29%
2016 -A$0.11 Billion-46.71%
2015 -A$0.21 Billion-19.31%
2014 -A$0.25 Billion64.11%
2013 -A$0.16 Billion180.06%
2012 -A$54.16 Million53.56%
2011 -A$35.27 Million55.87%
2010 -A$22.63 Million-48.27%
2009 -A$43.74 Million-24.64%
2008 -A$58.04 Million-85.11%
2007 -A$0.39 Billion6.61%
2006 -A$0.37 Billion18539.02%
2005 -A$1.97 Million-32.33%
2004 -A$2.9 Million-45.53%
2003 -A$5.33 Million-64.7%
2002 -A$15.08 Million2.99%
2001 -A$14.64 Million16.9%
2000 -A$12.53 Million104.81%
1999 -A$6.12 Million40.03%
1998 -A$4.37 Million-0%
1997 -A$4.37 Million7.14%
1996 -A$4.08 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
A$27.24 B-11,865.19%๐Ÿ‡บ๐Ÿ‡ธ USA
Abbott Laboratories
ABT
A$10.50 B-4,636.14%๐Ÿ‡บ๐Ÿ‡ธ USA
Regeneron Pharmaceuticals
REGN
A$8.27 B-3,673.86%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
A$16.49 B-7,221.58%๐Ÿ‡บ๐Ÿ‡ธ USA
LabCorp
LH
A$2.11 B-1,014.39%๐Ÿ‡บ๐Ÿ‡ธ USA
Alnylam Pharmaceuticals
ALNY
A$1.77 B-867.62%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
A$1.78 B-869.22%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
Ardelyx
ARDX
-A$80.42 Million-65.28%๐Ÿ‡บ๐Ÿ‡ธ USA